Affiliated Managers Group, Inc., through its affiliates, operates as an investment management company providing investment management services to mutual funds, institutional clients,retails and high net worth individuals in the United States. It provides advisory or sub-advisory services to mutual funds. These funds are distributed to retail, high net worth and institutional clients directly and through intermediaries, including independent investment advisors, retirement plan sponsors, broker-dealers, major fund marketplaces, and bank trust departments. The company also offers investment products in various investment styles in the institutional distribution channel, including small, small/mid, mid, and large capitalization value and growth equity, and emerging markets. In addition, it offers quantitative, alternative, and fixed income products, and manages assets for foundations and endowments, defined benefit, and defined contribution plans for corporations and municipalities. Affiliated Managers Group provides investment management or customized investment counseling and fiduciary services. Affiliated Managers Group, Inc. was formed in 1993 and is based in West Palm Beach, Florida with additional offices in Prides Crossing, Massachusetts; Stamford, Connecticut; London, United Kingdom; Dubai, United Arab Emirates; Sydney, Australia; Hong Kong; Tokyo, Japan, Zurich, Switzerland and Delaware.

Affiliated Managers Group, Inc.

Insiders have been trading these 5 stocks: (($AMGN)), (($CEG)), (($FSLY)), (($KEEL)) and (($BX)). Here is a breakdown of their recent trades and th...

Amgen, Constellation, Fastly, Keel & Blackstone Shock Wall St.

Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen Inc. (AMGN) is launching a new Phase 2/3 study called “A Trial of Ineb...

Amgen Targets Autoimmune Hepatitis With New Inebilizumab Trial

In a report released yesterday, Courtney Breen from Bernstein maintained a Hold rating on Amgen, with a price target of $345.00. The company’s shar...

Bernstein Reaffirms Their Hold Rating on Amgen (AMGN)

In a report released today, Michael Yee from UBS maintained a Buy rating on Amgen, with a price target of $440.00. Yee covers the Healthcare sector...

UBS Keeps Their Buy Rating on Amgen (AMGN)

In a report released today, Geoff Meacham from Citi maintained a Hold rating on Amgen, with a price target of $345.00. Meacham covers the Healthcar...

Citi Keeps Their Hold Rating on Amgen (AMGN)

TD Cowen analyst Yaron Werber reiterated a Buy rating on Amgen yesterday and set a price target of $452.00. According to TipRanks, Werber is a 5-st...

TD Cowen Sticks to Its Buy Rating for Amgen (AMGN)

Amgen Inc ($AMGN) announced an update on their ongoing clinical study. The Phase 3 MARITIME-1-EXTENSION study from Amgen Inc. looks at how well and...

Amgen Extends Obesity Trial, Sharpening Its Long-Term Weight-Loss Bet

Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen Inc. (AMGN) is running an early-stage study called “A Trial Evaluating...

Amgen’s AMG 127 Trial Signals a New Push Into Type 2 Diabetes

There’s a lot to be optimistic about in the Financial sector as 2 analysts just weighed in on AIA Group (AAIGF) and Affiliated Managers (AMG) with ...

Analysts Offer Insights on Financial Companies: AIA Group (OtherAAIGF) and Affiliated Managers (AMG)

RBC Capital analyst Luca Issi maintained a Buy rating on Amgen on July 29 and set a price target of $370.00. The company’s shares closed yesterday ...

RBC Capital Remains a Buy on Amgen (AMGN)

Dividend ETFs are one of the most popular ways to earn passive income, but choosing the right fund isn’t always easy. Among the leading options are...

SCHD vs. VYMI: Which Dividend ETF Comes Out on Top?

An update from AMG ADVANCED METALLURGICAL GROUP NV ( ($NL:AMG) ) is now available. AMG Critical Materials N.V., a global producer of critical mater...

AMG Critical Materials Holds Interim Dividend Steady at €0.20 per Share

Amigo Holdings PLC ( ($GB:AMGO) ) has provided an announcement. Amigo Resources PLC has changed its accounting reference date from 30 September to ...

Amigo Resources Aligns Financial Year End with Subsidiaries

The latest announcement is out from Global Asset Management Group ( ($GAMG) ). On July 24, 2026, Global Asset Management Group appointed Daniel Bel...

Global Asset Management Group Adds Advisors to Drive Growth

The latest announcement is out from AMG ADVANCED METALLURGICAL GROUP NV ( ($NL:AMG) ). AMG Critical Materials N.V. has completed the previously ann...

AMG Completes Sale of Graphit Kropfmühl to Sharpen Critical Materials Focus

SilverCrest Asset Management ( ($SAMG) ) has issued an update. Silvercrest Asset Management Group Inc. announced on July 27, 2026, that it will hol...

SilverCrest Asset Management Schedules Q2 2026 Investor Call

AMG ADVANCED METALLURGICAL GROUP NV ( ($NL:AMG) ) has issued an update. AMG Critical Materials N.V., a global supplier of critical materials and ad...

AMG Completes Full Acquisition of Zinnwald Lithium to Advance European Lithium Project

Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen Inc. has ended a late-stage study of rocatinlimab in prurigo nodularis...

Amgen Halts Key Phase 3 Rocatinlimab Study, Resetting Expectations in Dermatology

Bernstein analyst Courtney Breen maintained a Hold rating on Amgen yesterday and set a price target of $335.00. The company’s shares closed yesterd...

AMG ADVANCED METALLURGICAL GROUP NV ( ($NL:AMG) ) has provided an update. AMG Critical Materials N.V., a global supplier of critical materials and ...

AMG Secures $700 Million in New Credit Facilities to Extend Maturities and Boost Liquidity

AMG ADVANCED METALLURGICAL GROUP NV ( ($NL:AMG) ) has issued an announcement. AMG Critical Materials N.V., a global supplier of critical materials ...

AMG Schedules Second-Quarter 2026 Results and Investor Call

MetalNRG Plc ( ($GB:AMG) ) has issued an announcement. Atlas Metals Group plc, a natural resources and energy company listed on the London Stock Ex...

Atlas Metals Raises New Equity to Cut Debt and Update Voting Rights

Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen Inc. has stopped a late stage study testing bemarituzumab in advanced ...

Amgen Halts Bemarituzumab Gastric Cancer Trial, Shifting Oncology Expectations

Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen Inc. (AMGN) has completed a Phase 1 trial that tests how its obesity d...

Amgen Advances Obesity Pipeline With Fresh Data on AMG 133 Injection Formats

Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen Inc. has halted a key Phase 3 maintenance study known as ROCKET-ASCEND...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	AMG	$374.37	+1.98%	277.97K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	AMG	$374.37	+2.0%	277.97K
3
4
5
6

AMG

Get Affiliated Managers Group, Inc. Data in Excel

Get Affiliated Managers Group, Inc. Data in Excel